» Articles » PMID: 30461195

VEGF-A Regulates Angiogenesis During Osseointegration of Ti Implants Via Paracrine/autocrine Regulation of Osteoblast Response to Hierarchical Microstructure of the Surface

Overview
Date 2018 Nov 22
PMID 30461195
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Establishment of a patent vasculature at the bone-implant interface plays a significant role in determining overall success of orthopedic and dental implants. Osteoblasts produce vascular endothelial growth factor-A (VEGF-A), an important regulator of angiogenesis during bone formation and healing, and the amount secreted is sensitive to titanium (Ti) surface microtopography and surface energy. The purpose of this study was to determine if surface properties modulate cellular response to VEGF-A. MG63 osteoblast-like cells were transfected with shRNA targeting VEGF-A at >80% knockdown. Cells stably silenced for VEGF-A secreted reduced levels of osteocalcin, osteoprotegerin, FGF-2, and angiopoietin-1 when cultured on grit-blasted/acid-etched (SLA) and hydrophilic SLA (modSLA) Ti surfaces and conditioned media from these cultures caused reduced angiogenesis in an endothelial tubule formation assay. Treatment of MG63 cells with 20 ng/mL rhVEGF-A rescued production in silenced cells and increased production of osteocalcin, osteoprotegerin, FGF-2, and angiopoietin-1, with greatest effects on control cells cultured on modSLA. Addition of a neutralization antibody against VEGF receptor 2 (VEGFR2; Flk-1) resulted in a significant increase in VEGF-A production. Overall, this study indicates that VEGF-A has two roles in osseointegration: enhanced angiogenesis and an autocrine/paracrine role in maturation of osteoblast-like cells in response to Ti surface properties. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 423-433, 2019.

Citing Articles

Wnt16 Increases Bone-to-Implant Contact in an Osteopenic Rat Model by Increasing Proliferation and Regulating the Differentiation of Bone Marrow Stromal Cells.

Berger M, Bosh K, Deng J, Jacobs T, Cohen D, Boyan B Ann Biomed Eng. 2024; 52(6):1744-1762.

PMID: 38517621 PMC: 11082046. DOI: 10.1007/s10439-024-03488-y.


Osseointegration of Titanium Implants in a Botox-Induced Muscle Paralysis Rat Model Is Sensitive to Surface Topography and Semaphorin 3A Treatment.

Deng J, Cohen D, Berger M, Sabalewski E, McClure M, Boyan B Biomimetics (Basel). 2023; 8(1).

PMID: 36975323 PMC: 10046785. DOI: 10.3390/biomimetics8010093.


Semaphorin 3A delivered by a rapidly polymerizing click hydrogel overcomes impaired implant osseointegration in a rat type 2 diabetes model.

Deng J, Cohen D, Sabalewski E, Van Duyn C, Wilson D, Schwartz Z Acta Biomater. 2022; 157:236-251.

PMID: 36435442 PMC: 10007856. DOI: 10.1016/j.actbio.2022.11.030.


Hypoxia-Inducible Factors Signaling in Osteogenesis and Skeletal Repair.

Qin Q, Liu Y, Yang Z, Aimaijiang M, Ma R, Yang Y Int J Mol Sci. 2022; 23(19).

PMID: 36232501 PMC: 9569554. DOI: 10.3390/ijms231911201.


Advances in the superhydrophilicity-modified titanium surfaces with antibacterial and pro-osteogenesis properties: A review.

Shao H, Ma M, Wang Q, Yan T, Zhao B, Guo S Front Bioeng Biotechnol. 2022; 10:1000401.

PMID: 36147527 PMC: 9485881. DOI: 10.3389/fbioe.2022.1000401.


References
1.
Dai J, Rabie A . VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res. 2007; 86(10):937-50. DOI: 10.1177/154405910708601006. View

2.
Holmes D, Zachary I . The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005; 6(2):209. PMC: 551528. DOI: 10.1186/gb-2005-6-2-209. View

3.
Harada S, Nagy J, Sullivan K, Thomas K, Endo N, Rodan G . Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest. 1994; 93(6):2490-6. PMC: 294462. DOI: 10.1172/JCI117258. View

4.
Rupp F, Scheideler L, Olshanska N, de Wild M, Wieland M, Geis-Gerstorfer J . Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J Biomed Mater Res A. 2005; 76(2):323-34. DOI: 10.1002/jbm.a.30518. View

5.
Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z . Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13(1):9-22. View